CoChat
Sign Up
Cited by 68

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

WANTED – Dead or alive: Myotubularins, a large disease-associated protein family

Raess, Matthieu A., Friant, Sylvie, Cowling, Belinda S., Laporte, Jocelyn·2017·Advances in Biological Regulation
DOI 10.1016/j.jbior.2016.09.001
Open this paper in CoChat — free account

Abstract

Myotubularins define a large family of proteins conserved through evolution. Several members are mutated in different neuromuscular diseases including centronuclear myopathies and Charcot-Marie-Tooth (CMT) neuropathies, or are linked to a predisposition to obesity and cancer. While some members have phosphatase activity against the 3-phosphate of phosphoinositides, regulating the phosphorylation status of PtdIns3P and PtdIns(3,5)P 2 implicated in membrane trafficking and autophagy, and producing PtdIns5P, others lack key residues in the catalytic site and are classified as dead-phosphatases. However, these dead phosphatases regulate phosphoinositide-dependent cellular pathways by binding to catalytically active myotubularins. Here we review previous studies on the molecular regulation and physiological roles of myotubularins. We also used the recent myotubularins three-dimensional structures to underline key residues that are mutated in neuromuscular diseases and required for enzymatic activity. In addition, through database mining and analysis, expression profile and specific isoforms of the different myotubularins are described in depth, as well as a revisited protein interaction network. Comparison of the interactome and expression data for each myotubularin highlights specific protein complexes and tissues where myotubularins should have a key regulatory role.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jbior.2016.09.001

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 72

  1. Agrawal, 2014, SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy, Am. J. Hum. Genet., 95, 218, 10.1016/j.ajhg.2014.07.004 · DOI
  2. Amoasii, 2012, Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice, PLoS Genet., 8, e1002965, 10.1371/journal.pgen.1002965 · DOI
  3. Azzedine, 2003, Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of charcot-marie-tooth disease associated with early-onset glaucoma, Am. J. Hum. Genet., 72, 1141, 10.1086/375034 · DOI
  4. Barr, 2013, Review series: Rab GTPases and membrane identity: causal or inconsequential?, J. Cell Biol., 202, 191, 10.1083/jcb.201306010 · DOI
  5. Begley, 2005, The structure and regulation of myotubularin phosphatases, Curr. Opin. Struct. Biol., 15, 614, 10.1016/j.sbi.2005.10.016 · DOI
  6. Begley, 2006, Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase, Proc. Natl. Acad. Sci. U. S. A., 103, 927, 10.1073/pnas.0510006103 · DOI
  7. Begley, 2003, Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome, Mol. Cell, 12, 1391, 10.1016/S1097-2765(03)00486-6 · DOI
  8. Berger, 2006, Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease), Glia, 54, 243, 10.1002/glia.20386 · DOI
  9. Berger, 2003, Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module, Proc. Natl. Acad. Sci. U. S. A., 100, 12177, 10.1073/pnas.2132732100 · DOI
  10. Berggard, 2006, 140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry, J. Proteome Res., 5, 669, 10.1021/pr050421l · DOI
  11. Blondeau, 2000, Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway, Hum. Mol. Genet., 9, 2223, 10.1093/oxfordjournals.hmg.a018913 · DOI
  12. Bolino, 2004, Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis, J. Cell Biol., 167, 711, 10.1083/jcb.200407010 · DOI
  13. Bolino, 2001, Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy, Neurogenetics, 3, 107, 10.1007/s100480000101 · DOI
  14. Bolino, 2000, Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2, Nat. Genet., 25, 17, 10.1038/75542 · DOI
  15. Bong, 2016, Crystal structure of human myotubularin-related protein 1 provides insight into the structural basis of substrate specificity, PLoS One, 11, e0152611, 10.1371/journal.pone.0152611 · DOI
  16. Buj-Bello, 2002, Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells, Hum. Mol. Genet., 11, 2297, 10.1093/hmg/11.19.2297 · DOI
  17. Bulley, 2015, Exploring phosphatidylinositol 5-phosphate 4-kinase function, Adv. Biol. Regul., 57, 193, 10.1016/j.jbior.2014.09.007 · DOI
  18. Cao, 2007, Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes, Traffic, 8, 1052, 10.1111/j.1600-0854.2007.00586.x · DOI · Paper page
  19. Choudhury, 2006, Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain, J. Biol. Chem., 281, 31762, 10.1016/S0021-9258(19)84091-7 · DOI
  20. Cui, 1998, Association of SET domain and myotubularin-related proteins modulates growth control, Nat. Genet., 18, 331, 10.1038/ng0498-331 · DOI
  21. Doerks, 2000, GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins, Trends Biochem. Sci., 25, 483, 10.1016/S0968-0004(00)01664-9 · DOI
  22. Fabre, 2000, Identification of functional PDZ domain binding sites in several human proteins, Mol. Biol. Rep., 27, 217, 10.1023/A:1011008313677 · DOI
  23. Firestein, 2000, Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9, Mol. Cell Biol., 20, 4900, 10.1128/MCB.20.13.4900-4909.2000 · DOI
  24. Firestein, 2002, Male infertility, impaired spermatogenesis, and azoospermia in mice deficient for the pseudophosphatase Sbf1, J. Clin. Invest., 109, 1165, 10.1172/JCI0212589 · DOI
  25. Giudici, 2016, Phosphatidylinositol 5-phosphate 4-kinase gamma (PI5P4Kgamma), a lipid signalling enigma, Adv. Biol. Regul., 61, 47, 10.1016/j.jbior.2015.11.007 · DOI
  26. Goldfarb, 1998, Missense mutations in desmin associated with familial cardiac and skeletal myopathy, Nat. Genet., 19, 402, 10.1038/1300 · DOI
  27. Gozani, 2003, The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor, Cell, 114, 99, 10.1016/S0092-8674(03)00480-X · DOI
  28. Gupta, 2013, Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish, PLoS Genet., 9, e1003583, 10.1371/journal.pgen.1003583 · DOI
  29. Hnia, 2011, Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle, J. Clin. Invest., 121, 70, 10.1172/JCI44021 · DOI
  30. Hotta, 2011, Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population, J. Hum. Genet., 56, 647, 10.1038/jhg.2011.74 · DOI
  31. Hu, 2011, Weaving the web of ER tubules, Cell, 147, 1226, 10.1016/j.cell.2011.11.022 · DOI
  32. Itoh, 2002, Phosphoinositide-binding domains: functional units for temporal and spatial regulation of intracellular signalling, Cell. Signal., 14, 733, 10.1016/S0898-6568(02)00028-1 · DOI
  33. Jean, 2012, Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling, Mol. Biol. Cell, 23, 2723, 10.1091/mbc.e12-05-0375 · DOI
  34. Jungbluth, 2008, Centronuclear (myotubular) myopathy, Orphanet J. Rare Dis., 3, 26, 10.1186/1750-1172-3-26 · DOI
  35. Keune, 2013, PtdIns5P and Pin1 in oxidative stress signaling, Adv. Biol. Regul., 53, 179, 10.1016/j.jbior.2013.02.001 · DOI
  36. Kim, 2003, Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase, Proc. Natl. Acad. Sci. U. S. A., 100, 4492, 10.1073/pnas.0431052100 · DOI
  37. Laporte, 2003, Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases, Hum. Mol. Genet., 12, R285, 10.1093/hmg/ddg273 · DOI
  38. Lecompte, 2008, PtdIns5P regulation through evolution: roles in membrane trafficking?, Trends Biochem. Sci., 33, 453, 10.1016/j.tibs.2008.07.002 · DOI
  39. Li, 2016, Defining the protein-protein interaction network of the human protein tyrosine phosphatase family, Mol. Cell Proteomics, 15, 3030, 10.1074/mcp.M116.060277 · DOI
  40. Lorenzo, 2006, Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions, J. Cell Sci., 119, 2953, 10.1242/jcs.03040 · DOI
  41. Mersiyanova, 2000, A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene, Am. J. Hum. Genet., 67, 37, 10.1086/302962 · DOI
  42. Mochizuki, 2003, Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9, Proc. Natl. Acad. Sci. U. S. A., 100, 9768, 10.1073/pnas.1333958100 · DOI
  43. Mochizuki, 2013, Phosphatidylinositol 3-phosphatase myotubularin-related protein 6 (MTMR6) is regulated by small GTPase Rab1B in the early secretory and autophagic pathways, J. Biol. Chem., 288, 1009, 10.1074/jbc.M112.395087 · DOI
  44. Nandurkar, 2001, Characterization of an adapter subunit to a phosphatidylinositol (3)P 3- phosphatase: identification of a myotubularin-related protein lacking catalytic activity, Proc. Natl. Acad. Sci. U. S. A., 98, 9499, 10.1073/pnas.171306098 · DOI
  45. Nandurkar, 2002, The myotubularin family: novel phosphoinositide regulators, IUBMB Life, 53, 37, 10.1080/15216540210812 · DOI
  46. Nandurkar, 2003, Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP, Proc. Natl. Acad. Sci. U. S. A., 100, 8660, 10.1073/pnas.1033097100 · DOI
  47. Nicot, 2008, Endosomal phosphoinositides and human diseases, Traffic, 9, 1240, 10.1111/j.1600-0854.2008.00754.x · DOI
  48. Plant, 2009, The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4, Biochem. J., 419, 57, 10.1042/BJ20081866 · DOI
  49. Previtali, 2003, Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve, Hum. Mol. Genet., 12, 1713, 10.1093/hmg/ddg179 · DOI
  50. Ramel, 2011, Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling, Sci. Signal, 4, ra61, 10.1126/scisignal.2001619 · DOI
  51. Robinson, 2006, Myotubularin phosphatases: policing 3-phosphoinositides, Trends Cell Biol., 16, 403, 10.1016/j.tcb.2006.06.001 · DOI
  52. Royer, 2013, The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies, EMBO Rep., 14, 907, 10.1038/embor.2013.119 · DOI
  53. Rual, 2005, Towards a proteome-scale map of the human protein-protein interaction network, Nature, 437, 1173, 10.1038/nature04209 · DOI
  54. Sabha, 2016, PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models, J. Clin. Invest., 126, 3613, 10.1172/JCI86841 · DOI
  55. Sanchez-Juan, 2012, Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk, Neurobiol. Aging, 33, 10.1016/j.neurobiolaging.2011.10.011 · DOI
  56. Schaletzky, 2003, Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases, Curr. Biol., 13, 504, 10.1016/S0960-9822(03)00132-5 · DOI
  57. Senderek, 2003, Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15, Hum. Mol. Genet., 12, 349, 10.1093/hmg/ddg030 · DOI
  58. Song, 2010, Calcineurin regulates coelomocyte endocytosis via DYN-1 and CUP-4 in Caenorhabditis elegans, Mol. Cells, 30, 255, 10.1007/s10059-010-0116-x · DOI
  59. Srivastava, 2005, The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1, Mol. Cell Biol., 25, 3630, 10.1128/MCB.25.9.3630-3638.2005 · DOI
  60. Staiano, 2015, Mendelian disorders of PI metabolizing enzymes, Biochim. Biophys. Acta, 1851, 867, 10.1016/j.bbalip.2014.12.001 · DOI
  61. Taylor, 2000, Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate, Proc. Natl. Acad. Sci. U. S. A., 97, 8910, 10.1073/pnas.160255697 · DOI
  62. Tosch, 2006, A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy, Hum. Mol. Genet., 15, 3098, 10.1093/hmg/ddl250 · DOI
  63. Tronchere, 2004, Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells, J. Biol. Chem., 279, 7304, 10.1074/jbc.M311071200 · DOI
  64. Tsujita, 2004, Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction, J. Biol. Chem., 279, 13817, 10.1074/jbc.M312294200 · DOI
  65. Velichkova, 2010, Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions, J. Cell Biol., 190, 407, 10.1083/jcb.200911020 · DOI
  66. Walker, 2001, Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity, Curr. Biol., 11, 1600, 10.1016/S0960-9822(01)00501-2 · DOI
  67. Weidner, 2016, Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer, Oncotarget, 7, 50490, 10.18632/oncotarget.10466 · DOI
  68. Yoshimura, 2010, Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors, J. Cell Biol., 191, 367, 10.1083/jcb.201008051 · DOI · Paper page
  69. Yu, 2013, Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins, J. Biol. Chem., 288, 79, 10.1074/jbc.M112.413856 · DOI
  70. Zhang, 2005, Endocrinology, 146, 1268, 10.1210/en.2004-1194 · DOI
  71. Zhang, 1994, Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates, Biochemistry, 33, 2285, 10.1021/bi00174a040 · DOI
  72. Zou, 2009, Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells, PLoS Genet., 5, e1000679, 10.1371/journal.pgen.1000679 · DOI

Cited by

Sorted by citations

See all 68

Metadata

Authors
Raess, M. A., Friant, S., Cowling, B. S., & Laporte, J.
Venue
Advances in Biological Regulation
Publisher
Elsevier BV
Published
2017-01
Volume
63
Pages
49-58
ISSN
2212-4926
DOI
10.1016/j.jbior.2016.09.001
Cited by
68
References
3
Language
en
Licence
Funders
  • Agence Nationale de la Recherche (ANR-13-BSV2-0004)
  • Association Française contre les Myopathies (AFM-SB/CP/2013-0133/16551)
  • Institut National de la Santé et de la Recherche Médicale
  • Université de Strasbourg
  • Centre National de la Recherche Scientifique

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review